Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT06361745 · UNKNOWN

Trial details

NCT number: NCT06361745
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathies Systemic Sclerosis IgG4 Related Disease Primary Sjögren Syndrome

Start date: 2024-04-02
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.